Department of Medical Physics, Tata Memorial Hospital, Parel, India.
Br J Radiol. 2009 Dec;82(984):1000-9. doi: 10.1259/bjr/13776022. Epub 2009 Jul 6.
This study aimed to establish the feasibility of intensity-modulated radiation therapy (IMRT) in craniospinal irradiation (CSI) using conventional linear accelerator (IMRT_LA) and compare it dosimetrically with helical TomoTherapy (IMRT_Tomo) and three-dimensional conformal radiotherapy (3DCRT). CT datasets of four previously treated patients with medulloblastoma were used to generate 3DCRT, IMRT_LA and IMRT_Tomo plans. A CSI dose of 35 Gy was prescribed to the planning target volume (PTV). IMRT_LA plans for tall patients were generated using an intensity feathering technique. All plans were compared dosimetrically using standardised parameters. The mean volume of each PTV receiving at least 95% of the prescribed dose (V(95%)) was >98% for all plans. All plans resulted in a comparable dose homogeneity index (DHI) for PTV_brain. For PTV_spine, IMRT_Tomo achieved the highest mean DHI of 0.96, compared with 0.91 for IMRT_LA and 0.84 for 3DCRT. The best dose conformity index was achieved by IMRT_Tomo for PTV_brain (0.96) and IMRT_LA for PTV_spine (0.83). The IMRT_Tomo plan was superior in terms of reduction of the maximum, mean and integral doses to almost all organs at risk (OARs). It also reduced the volume of each OAR irradiated to various dose levels, except for the lowest dose volume. The beam-on time was significantly longer in IMRT_Tomo. In conclusion, IMRT_Tomo for CSI is technically easier and potentially dosimetrically favourable compared with IMRT_LA and 3DCRT. IMRT for CSI can also be realised on a conventional linear accelerator even for spinal lengths exceeding maximum allowable field sizes. The longer beam-on time in IMRT_Tomo raises concerns about intrafraction motion and whole-body integral doses.
本研究旨在评估使用常规线性加速器(IMRT_LA)行颅脊髓照射(CSI)的强度调制放射治疗(IMRT)的可行性,并与螺旋断层放疗(IMRT_Tomo)和三维适形放疗(3DCRT)进行剂量学比较。我们使用 4 例已接受治疗的髓母细胞瘤患者的 CT 数据集生成 3DCRT、IMRT_LA 和 IMRT_Tomo 计划。将计划靶区(PTV)的 CSI 剂量设定为 35 Gy。对身高较高的患者采用强度渐变技术生成 IMRT_LA 计划。使用标准化参数对所有计划进行剂量学比较。所有计划的 PTV 至少接受 95%处方剂量的体积(V(95%))均>98%。所有计划的 PTV_brain 剂量均匀性指数(DHI)相似。对于 PTV_spine,IMRT_Tomo 获得的平均 DHI 最高,为 0.96,IMRT_LA 为 0.91,3DCRT 为 0.84。IMRT_Tomo 对 PTV_brain 的剂量适形指数最高(0.96),IMRT_LA 对 PTV_spine 的剂量适形指数最高(0.83)。在降低危及器官(OAR)的最大剂量、平均剂量和积分剂量方面,IMRT_Tomo 计划具有优势。除了最低剂量体积外,它还降低了各个 OAR 受到各种剂量照射的体积。IMRT_Tomo 的射束开启时间显著更长。总之,与 IMRT_LA 和 3DCRT 相比,IMRT_Tomo 用于 CSI 在技术上更简单,且潜在的剂量学更有利。即使对于脊髓长度超过最大允许野大小的情况,常规线性加速器也可以实现 CSI 的 IMRT。IMRT_Tomo 较长的射束开启时间引起了对分次内运动和全身积分剂量的担忧。